KYOWA HAKKO BIO CO., LTD. (Kyowa Hakko Bio) is pleased to announce that its manufacturing strain used for producing 2'-fucosyllactose (2’-FL), the most abundant HMO in human milk, has passed the safety...

Kyowa Hakko Europe, a leading international health ingredient manufacturer, is pleased to announce this prestigious NutraIngredients Award given to its flagship product Cognizin® Citicoline...

With an impressive background in mining the microbiome for novel therapies, Prof. Hill helped with the definition of a postbiotic as a part of ISAPP.

Findings published in The Journal of Nutrition demonstrate supplementation of citicoline for improved overall memory performance in healthy elderly populations.

Strengthen Your Body’s Defenses from the Inside with IMMUSE®. A patented unique strain of <em>Lactococcus lactis</em> provides a more comprehensive approach to immune support...

KYOWA HAKKO BIO CO. LTD., a subsidiary of Kirin Holdings Company, has announced that it will establish a new facility to manufacture human milk oligosaccharides (HMOs) in Thailand. Kyowa Hakko Bio decided on the move with expectations of a future increase in global demand for HMOs. This move further expands its global footprint to consolidate its position as a global...

Serious athletes know the key to top performance is hydration. Keeping the body fueled with water and other nutrients can mean the difference between first and second place.

Glutathione—called nature’s “master antioxidant”—is a powerful defender against these attackers and is essential for good immune health. But the constant barrage depletes glutathione levels, lessening your body’s ability to fight back*.

<p> </p>

<p> </p>